BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,909,573 | -20.7% | 368,563 | -4.3% | 0.01% | -20.0% |
| Q2 2023 | $17,540,629 | +9.4% | 385,001 | -2.6% | 0.02% | +7.1% |
| Q1 2023 | $16,028,689 | -29.9% | 395,185 | -12.0% | 0.01% | -36.4% |
| Q4 2022 | $22,876,610 | -11.5% | 448,825 | -6.4% | 0.02% | -18.5% |
| Q3 2022 | $25,836,000 | -18.4% | 479,685 | -2.7% | 0.03% | -12.9% |
| Q2 2022 | $31,657,000 | -21.7% | 492,853 | -5.5% | 0.03% | -11.4% |
| Q1 2022 | $40,432,000 | -10.7% | 521,431 | -1.2% | 0.04% | -5.4% |
| Q4 2021 | $45,299,000 | +7.9% | 527,720 | +1.1% | 0.04% | -5.1% |
| Q3 2021 | $41,971,000 | -4.8% | 521,805 | -4.7% | 0.04% | -2.5% |
| Q2 2021 | $44,091,000 | -11.8% | 547,705 | -7.6% | 0.04% | -18.4% |
| Q1 2021 | $49,978,000 | -6.2% | 592,580 | -10.8% | 0.05% | -9.3% |
| Q4 2020 | $53,286,000 | -4.5% | 664,073 | -4.3% | 0.05% | -21.7% |
| Q3 2020 | $55,821,000 | -54.0% | 694,107 | -50.7% | 0.07% | -57.1% |
| Q2 2020 | $121,233,000 | +6.9% | 1,408,045 | +0.8% | 0.16% | +12.6% |
| Q1 2020 | $113,417,000 | -6.8% | 1,396,942 | -4.0% | 0.14% | +19.2% |
| Q4 2019 | $121,712,000 | -7.2% | 1,455,566 | -2.9% | 0.12% | -8.4% |
| Q3 2019 | $131,140,000 | +3.8% | 1,499,260 | -2.8% | 0.13% | +5.6% |
| Q2 2019 | $126,373,000 | -5.0% | 1,542,999 | -5.7% | 0.12% | -6.8% |
| Q1 2019 | $133,025,000 | +19.1% | 1,636,039 | -3.6% | 0.13% | +7.3% |
| Q4 2018 | $111,678,000 | -19.5% | 1,696,697 | -5.7% | 0.12% | -6.1% |
| Q3 2018 | $138,728,000 | +5.3% | 1,799,545 | +0.9% | 0.13% | +1.5% |
| Q2 2018 | $131,738,000 | +22.6% | 1,784,108 | +8.0% | 0.13% | +22.6% |
| Q1 2018 | $107,487,000 | +105.1% | 1,652,618 | +103.8% | 0.11% | +107.8% |
| Q4 2017 | $52,414,000 | +9.9% | 810,885 | +6.7% | 0.05% | +2.0% |
| Q3 2017 | $47,701,000 | +12.3% | 760,144 | +8.3% | 0.05% | +8.7% |
| Q2 2017 | $42,489,000 | +9.1% | 701,869 | -6.6% | 0.05% | +7.0% |
| Q1 2017 | $38,952,000 | +15.4% | 751,068 | -1.4% | 0.04% | +13.2% |
| Q4 2016 | $33,762,000 | -7.3% | 761,402 | -0.4% | 0.04% | -9.5% |
| Q3 2016 | $36,402,000 | +4.8% | 764,761 | -0.4% | 0.04% | +2.4% |
| Q2 2016 | $34,722,000 | +5.2% | 767,864 | -4.4% | 0.04% | +5.1% |
| Q1 2016 | $33,002,000 | +12.7% | 803,370 | +4.6% | 0.04% | +11.4% |
| Q4 2015 | $29,292,000 | +0.2% | 767,788 | -13.7% | 0.04% | 0.0% |
| Q3 2015 | $29,230,000 | -57.2% | 889,786 | -9.0% | 0.04% | -53.9% |
| Q2 2015 | $68,353,000 | -20.6% | 977,448 | -22.3% | 0.08% | -20.0% |
| Q1 2015 | $86,121,000 | -22.6% | 1,257,272 | -17.2% | 0.10% | -22.1% |
| Q4 2014 | $111,309,000 | +5.7% | 1,518,759 | +3.5% | 0.12% | -1.6% |
| Q3 2014 | $105,329,000 | +10.7% | 1,467,591 | +11.5% | 0.12% | +2.5% |
| Q2 2014 | $95,129,000 | +1.6% | 1,315,756 | +3.4% | 0.12% | -1.6% |
| Q1 2014 | $93,625,000 | +0.1% | 1,272,423 | -5.3% | 0.12% | -0.8% |
| Q4 2013 | $93,499,000 | -25.0% | 1,344,339 | -29.2% | 0.12% | -31.9% |
| Q3 2013 | $124,674,000 | +73.6% | 1,897,915 | +83.0% | 0.18% | +73.3% |
| Q2 2013 | $71,828,000 | – | 1,036,931 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |